Another study has been published on the efficacy of acupuncture in the treatment of hot flashes.

Having used this treatment for many of my patients (men and women) with hormone therapy-induced hot flashes, I am not surprised at the published results.

The patients included a small cohort of men with prostate cancer who were being treated with androgen deprivation therapy (ADT). The investigators used a simple protocol of electroacupuncture (sorry for the acupuncture lingo to follow: 10 bilateral points at GB34, SP6, KI3, ST36, BL15, BL23, Taiyang, HT7, PC6, LI11; De Qi was elicited at all points and 2Hz was applied at SP6, ST36, BL15, BL23). The treatments each lasted 30 minutes and were done twice a week for 4 weeks.

Patients were given a hot flash score (HFS) questionnaire to complete for the entire length of the study. The HFS is a product of the hot flash frequency and severity (1=mild, 2=moderate, 3=severe). The HFS is an accepted assessment used in many other studies.

The results were fantastic:

  • Mean improvement in HFS at 2-weeks=68% and at 6-weeks=89%.
  • Amazingly, 8-months after the completion of the acupuncture treatment, the patients still recorded a mean improvement of 80% from their pre-acupuncture baseline!!
  • There were no side effects from this treatment.

If you are living with hot flashes from ADT, give acupuncture a try.

Learn more about complementary therapies in cancer care here.

Become a FAN to follow us on Facebook

 

Share
 
Greater than 50% of breast cancer patients either discontinue or are non-adherent to hormonal therapy regimens

In a study published, in June 2010 (in the Journal of Clinical Oncology) investigators have found that over 50% of breast cancer patients, who have been prescribed hormonal therapy medications (“aromatase inhibitors” or “Tamoxifen”) for preventing recurrence of breast cancer, either prematurely discontinue or do not take their medication as prescribed (“non-adherence” was defined in this study as, taking <80% of the prescribed pills.) All patients in this study (8,769 patients) had “estrogen positive”, invasive breast cancers (stages 1-3) and were therefore recommended to take hormonal therapy for a total of 5-years.  Previous studies have demonstrated that patients who take less than 5-years [...read more...]

Share
 
Progesterone increases the risk of breast cancer metastasis

In a study (accepted for publication in May 2006, in Menopause: The Journal of The North American Menopause Society) investigators found the the use of progesterone increased the risk of breast cancer metastases. The authors conducted this study in animals with breast cancer. They noted that progesterone’s effect was not dependent on the menopausal status of the animal nor whether the progesterone was given with or without estrogen. It appeared that progesterone stimulated the production of blood vessels to the tumors, increasing their access to the circulation and the rest of the body. (Read More Here) Millions of women, after [...read more...]

Share
© 2011 Integrative Oncology Essentials Suffusion theme by Sayontan Sinha